関連レポート

インフルエンザ診断市場：2031年予測

出版元：Transparency Market Research  出版元について

発行年：2024年4月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 212ページになります。

商品コード：TMR247

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

マイコプラズマ診断の世界市場規模は2023年で10億ドル、2034年に21億ドル、市場の平均年成長率は7.4%にて増加する見込みです。

当レポートでは、マイコプラズマ診断の市場予測-2034年、各種セグメント別市場分析(製品別、技術別、国地域別、等)、パイプライン分析、主要製品/ブランド分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■マイコプラズマ診断の世界市場予測2020-2034年
・市場規模(US$)

■製品別、市場-2034年
・キット、試薬
・機器
・ソフトウェア、サービス
※(市場規模US$)　

■技術別、市場-2034年
PCR
免疫測定法
・ELISA
・RIA
DNA染色
微生物培養
その他
※(市場規模US$)

■エンドユーザー別、市場-2034年
・病院
・診断研究所
・診療所
・その他
※(市場規模US$)　

■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス
パイプライン分析
主要製品/ブランド分析
主要な合併、買収

■マイコプラズマ診断の主要企業プロフィール動向
Merck & Co., Inc.
F. Hoffmann-La Roche AG
Agilent Technologies
Sartorius AG
Savyon Diagnostics
タカラバイオ株式会社
Lonza Group
Charles River Laboratories International, Inc.
Thermo Fisher Scientific Inc.
PromoCell GmbH

（全212頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Mycoplasma Diagnostics Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Mycoplasma Diagnostics Market Analysis and Forecast, 2020-2034

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Mycoplasma Diagnostics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2020-2034
6.3.1. Kits & Reagents
6.3.2. Instruments
6.3.3. Software & Services
6.4. Market Attractiveness Analysis, by Product

7. Global Mycoplasma Diagnostics Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020-2034
7.3.1. PCR
7.3.2. Immunoassay
7.3.2.1. ELISA
7.3.2.2. RIA
7.3.3. DNA Staining
7.3.4. Microbial Culture Techniques
7.3.5. Others
7.4. Market Attractiveness Analysis, by Technology

8. Global Mycoplasma Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Direct Sales
8.3.2. Distributors
8.4. Market Attractiveness Analysis, by End-user

9. Global Mycoplasma Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Mycoplasma Diagnostics Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2020-2034
10.3.1. Kits & Reagents
10.3.2. Instruments
10.3.3. Software & Services
10.4. Market Value Forecast, by Technology, 2020-2034
10.4.1. PCR
10.4.2. Immunoassay
10.4.2.1. ELISA
10.4.2.2. RIA
10.4.3. DNA Staining
10.4.4. Microbial Culture Techniques
10.4.5. Others
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Direct Sales
10.5.2. Distributors
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Technology
10.7.3. By End-user
10.7.4. By Country

11. Europe Mycoplasma Diagnostics Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2020-2034
11.3.1. Kits & Reagents
11.3.2. Instruments
11.3.3. Software & Services
11.4. Market Value Forecast, by Technology, 2020-2034
11.4.1. PCR
11.4.2. Immunoassay
11.4.2.1. ELISA
11.4.2.2. RIA
11.4.3. DNA Staining
11.4.4. Microbial Culture Techniques
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Direct Sales
11.5.2. Distributors
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Technology
11.7.3. By End-user
11.7.4. By Country/Sub-region

12. Asia Pacific Mycoplasma Diagnostics Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2020-2034
12.3.1. Kits & Reagents
12.3.2. Instruments
12.3.3. Software & Services
12.4. Market Value Forecast, by Technology, 2020-2034
12.4.1. PCR
12.4.2. Immunoassay
12.4.2.1. ELISA
12.4.2.2. RIA
12.4.3. DNA Staining
12.4.4. Microbial Culture Techniques
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Direct Sales
12.5.2. Distributors
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Technology
12.7.3. By End-user
12.7.4. By Country/Sub-region

13. Latin America Mycoplasma Diagnostics Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2020-2034
13.3.1. Kits & Reagents
13.3.2. Instruments
13.3.3. Software & Services
13.4. Market Value Forecast, by Technology, 2020-2034
13.4.1. PCR
13.4.2. Immunoassay
13.4.2.1. ELISA
13.4.2.2. RIA
13.4.3. DNA Staining
13.4.4. Microbial Culture Techniques
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Direct Sales
13.5.2. Distributors
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Technology
13.7.3. By End-user
13.7.4. By Country/Sub-region

14. Middle East & Africa Mycoplasma Diagnostics Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2020-2034
14.3.1. Kits & Reagents
14.3.2. Instruments
14.3.3. Software & Services
14.4. Market Value Forecast, by Technology, 2020-2034
14.4.1. PCR
14.4.2. Immunoassay
14.4.2.1. ELISA
14.4.2.2. RIA
14.4.3. DNA Staining
14.4.4. Microbial Culture Techniques
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Direct Sales
14.5.2. Distributors
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Technology
14.7.3. By End-user
14.7.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Agilent Technologies
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Sartorius AG
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Savyon Diagnostics
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Takara Bio Inc. (Takara Holding Company Inc.)
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Lonza Group
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Merck & Co., Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Charles River Laboratories International, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Thermo Fisher Scientific Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. PromoCell GmbH
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview

List of Tables

Table 01: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 02: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 03: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 04: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 05: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 06: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 07: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 08: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 09: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 11: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 12: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 13: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 15: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 16: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 17: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 18: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 19: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 20: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 21: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 23: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 24: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Global Mycoplasma Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Mycoplasma Diagnostics Market Revenue (US$ Mn), by Product, 2023

Figure 03: Global Mycoplasma Diagnostics Market Value Share, by Product, 2023

Figure 04: Global Mycoplasma Diagnostics Market Revenue (US$ Mn), by Technology, 2023

Figure 05: Global Mycoplasma Diagnostics Market Value Share, by Technology, 2023

Figure 06: Global Mycoplasma Diagnostics Market Revenue (US$ Mn), by End-user, 2023

Figure 07: Global Mycoplasma Diagnostics Market Value Share, by End-user, 2023

Figure 08: Global Mycoplasma Diagnostics Market Value Share, by Region, 2023

Figure 09: Global Mycoplasma Diagnostics Market Value (US$ Mn) Forecast, 2020-2034

Figure 10: Global Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

Figure 11: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034

Figure 12: Global Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034

Figure 13: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034

Figure 14: Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 15: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 16: Global Mycoplasma Diagnostics Market Value Share Analysis, by Region, 2023 and 2034

Figure 17: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034

Figure 18: North America Mycoplasma Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 19: North America Mycoplasma Diagnostics Market Attractiveness Analysis, by Country, 2024-2034

Figure 20: North America Mycoplasma Diagnostics Market Value Share Analysis, by Country, 2023 and 2034

Figure 21: North America Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

Figure 22: North America Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034

Figure 23: North America Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 24: North America Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034

Figure 25: North America Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034

Figure 26: North America Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 27: Europe Mycoplasma Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 28: Europe Mycoplasma Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 29: Europe Mycoplasma Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 30: Europe Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

Figure 31: Europe Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034

Figure 32: Europe Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 33: Europe Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034

Figure 34: Europe Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034

Figure 35: Europe Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 36: Asia Pacific Mycoplasma Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 37: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 38: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 39: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

Figure 40: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034

Figure 41: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 42: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034

Figure 43: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034

Figure 44: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 45: Latin America Mycoplasma Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 46: Latin America Mycoplasma Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 47: Latin America Mycoplasma Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Latin America Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

Figure 49: Latin America Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034

Figure 50: Latin America Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 51: Latin America Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034

Figure 52: Latin America Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034

Figure 53: Latin America Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 54: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 55: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 56: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034

Figure 58: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034

Figure 59: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034

Figure 60: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034

Figure 61: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034

Figure 62: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

△ 一番上に戻る